SCHEMBL5146010

SCHEMBL5146010

CC1(C)NC(=O)N(CCNc2ncc(C(F)(F)F)c(-c3cc4cc([N+](=O)[O-])ccc4s3)n2)C1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.35
LMNA P02545 4/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
RAB9A P51151 3/20 0.35
AR P10275 2/20 0.35
ALDH1A1 P00352 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
TP53 P04637 1/20 0.35
PGR P06401 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
TSHR P16473 1/20 0.35
ALOX12 P18054 1/20 0.35
NFKB1 P19838 1/20 0.35
PDE4D Q08499 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5147302 0.88 ALDH1A1 (0.36) POLBLMNASMN1; SMN2RAB9AALDH1A1
SCHEMBL2984250 0.88 POLB (0.36) POLBLMNASMN1; SMN2RAB9AAR
SCHEMBL5147311 0.87 LMNA (0.37) LMNASMN1; SMN2ARALDH1A1KMT2A
SCHEMBL5147509 0.84 ALDH1A1 (0.38) POLBLMNASMN1; SMN2RAB9AALDH1A1
SCHEMBL5147345 0.83 LMNA (0.37) LMNASMN1; SMN2ARALDH1A1TSHR
SCHEMBL5148410 0.82 LMNA (0.39) LMNASMN1; SMN2ARALDH1A1TSHR
SCHEMBL2976991 0.76 POLB (0.35) POLBLMNASMN1; SMN2RAB9AALDH1A1
SCHEMBL5147313 0.76 ALDH1A1 (0.35) LMNASMN1; SMN2RAB9AALDH1A1TSHR
SCHEMBL5147455 0.75 PLA2G7 (0.37) LMNAARALDH1A1HTTUSP2
SCHEMBL2986071 0.75 PDGFRB (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831207-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-09-12 EP disclosed
WO-2006066172-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE AMGEN, INC. (US) 2006-06-22 WO disclosed